NAD+-Dependent Enzymatic Route for the Epimerization of Hydroxysteroids

Journal Article (2018)
Author(s)

Fabio Tonin (TU Delft - Applied Sciences)

Linda G. Otten (TU Delft - Applied Sciences)

Isabel W.C.E. Arends (Universiteit Utrecht, TU Delft - Applied Sciences)

Research Group
BT/Biocatalysis
DOI related publication
https://doi.org/10.1002/cssc.201801862 Final published version
More Info
expand_more
Publication Year
2018
Language
English
Research Group
BT/Biocatalysis
Journal title
ChemSusChem
Volume number
11
Downloads counter
230

Abstract

Epimerization of cholic and chenodeoxycholic acid (CA and CDCA, respectively) is a notable conversion for the production of ursodeoxycholic acid (UDCA). Two enantiocomplementary hydroxysteroid dehydrogenases (7α- and 7β-HSDHs) can carry out this transformation fully selectively by specific oxidation of the 7α-OH group of the substrate and subsequent reduction of the keto intermediate to the final product (7β-OH). With a view to developing robust and active biocatalysts, novel NADH-active 7β-HSDH species are necessary to enable a solely NAD+-dependent redox-neutral cascade for UDCA production. A wild-type NADH-dependent 7β-HSDH from Lactobacillus spicheri (Ls7β-HSDH) was identified, recombinantly expressed, purified, and biochemically characterized. Using this novel NAD+-dependent 7β-HSDH enzyme in combination with 7α-HSDH from Stenotrophomonas maltophilia permitted the biotransformations of CA and CDCA in the presence of catalytic amounts of NAD+, resulting in high yields (>90 %) of UCA and UDCA.